Lutetium-177Lu oxodotreotide

lutetium-177 dotatate · Advanced Accelerator Applications (Novartis)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lutetium-177Lu oxodotreotide, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs [Phase 3]

See pricing